🇺🇸 FDA
Pipeline program

MPs

MPs-AL-2014

Phase 3 mab active

Quick answer

MPs for Hematological Diseases is a Phase 3 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hematological Diseases
Phase
Phase 3
Modality
mab
Status
active

Clinical trials